The Simplify Propel Opportunities ETF (SURI) aims to deliver substantial long-term capital growth. It achieves this by investing in companies across the biotechnology, pharmaceutical, healthcare technology, and life sciences industries. These particular firms are selected because they are believed to be overlooked by investors, suggesting significant potential for their value to increase. Propel, the fund's sub-advisor, applies its deep scientific and commercial knowledge in health sciences to identify and select the most promising investment opportunities within this sector.

ประเภทสินทรัพย์

Equity

ผู้ออกกองทุน

Simplify

ประเทศที่จดทะเบียน

US

วันที่จัดตั้ง

7 ก.พ. 2566

จำนวนหลักทรัพย์

19

ISIN

US82889N6242